Company Filing History:
Years Active: 2023
Title: **Hanna Leinonen: Pioneering Innovations in Plasmid Transfection**
Introduction
Hanna Leinonen, an innovative inventor based in Kuopio, Finland, is making strides in the field of genetic engineering. With a focus on plasmid transfection, she has developed a unique approach that enhances the production of viral vectors. Her groundbreaking work is paving the way for advancements in biotherapeutics.
Latest Patents
Hanna Leinonen holds a significant patent titled "Large-scale PEI-mediated plasmid transfection." This invention addresses the challenges associated with traditional methods of plasmid transfection. Her approach effectively utilizes polyethyleneimine (PEI) as a transfection agent in fixed bed or adherent cell culture bioreactors. Notably, her innovation eliminates the formation of PEI-plasmid precipitate, which has previously hindered the performance of adherent bioreactor substrates. Furthermore, Hanna's work incorporates novel methods to improve the management of pH and carbon dioxide levels during the transfection process.
Career Highlights
Currently, Hanna is employed at Trizell Limited, where she applies her expertise to enhance the capabilities of plasmid transfection. Her contribution to the field is significant, as she combines scientific knowledge with practical applications to improve biotechnological processes.
Collaborations
Throughout her career, Hanna has collaborated with talented coworkers, including Hanna P Lesch and Joonas Malinen. Their combined efforts foster a creative environment that promotes innovation and research advancements.
Conclusion
Hanna Leinonen is a remarkable figure in the realm of genetic engineering. Her patented processes and collaborative work at Trizell Limited demonstrate her commitment to innovation and improvement in plasmid transfection technologies. As the field evolves, her contributions will undoubtedly play a crucial role in shaping the future of biotherapeutics.